De-escalation of medical therapy in inflammatory bowel disease.

Frias Gomes, Catarina; Chapman, Thomas P; Satsangi, Jack

Frias Gomes, Catarina; Chapman, Thomas P; Satsangi, Jack.

Affiliation

Frias Gomes C; Surgical Department, Gastroenterology Division, Hospital Beatriz Ângelo, Loures, Portugal. Electronic address: catarinagomes27@gmail.com.
Chapman TP; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.

Curr Opin Pharmacol ; 55: 73-81, 2020 12.

Article in En | MEDLINE | ID: mdl-33160250

Subject(s)

Biological Therapy/methods; Immunologic Factors/therapeutic use; Inflammatory Bowel Diseases/drug therapy; Mesalamine/therapeutic use; Safety-Based Drug Withdrawals/methods; Humans; Immunologic Factors/adverse effects; Mesalamine/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Therapy / Inflammatory Bowel Diseases / Mesalamine / Safety-Based Drug Withdrawals / Immunologic Factors Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Curr Opin Pharmacol Journal subject: FARMACOLOGIA Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google